Pre-Conference Focus Day
Tuesday July 26,2022
8:00 am Registration & Morning Networking Coffee
8:50 am Chair Person’s Opening Remarks
9:00 am Biotechnology Leaders Fireside Chat
- Shiv Krishnan Head - External Innovation; Biologics R&D, Lonza AG
- Joe Payne Founder, President & CEO , Arcturus Therapeutics
- Jacob Becraft Co-Founder & CEO, Strand Therapeutics
- Jenny van Asbeck – van der Wijst CEO, Mercurna
- Nathaniel Wang CEO & Co-Founder, Replicate Bioscience
Ask your burning questions to industry pioneers who will discuss the new frontiers in mRNA technology, the hottest indications at the forefront of scientific research and the future for the next wave of mRNA.
- What does the future look like for the next generation of mRNA- based therapeutics for clinically relevant targets?
- Where do we expect new innovations to come from and what challenges are ahead of us?
- What limits actual development where mRNA might be leveraged to replace existing technologies?
10:00 am Navigating the IP Landscape in the mRNA Space
- Daniel Shores Partner, Rothwell Figg
- The current IP and competitive landscape for mRNA and LNP delivery technology
- Strategies for freedom to operate, design-around, and licensing
- IP protection strategies for new innovations